Lifevantage Corp
For the period ended Mar 31, 2024. Filed May 2, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed May 2, 2024
LFVN$5.29+1.3%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 6. Exhibits
| Exhibit No. | Document Description | Filed Herewith or Incorporate by Reference From |
| 3.1 | Certificate of Incorporation, as filed with the Delaware Secretary of State on March 9, 2018 | Exhibit 3.1 to the Current Report on Form 8-K filed with the SEC on March 13, 2018. |
| 3.2 | Amended and Restated Bylaws, August 9, 2019 | Exhibit 3.1 to the Current Report on Form 8-K filed with the SEC on August 15, 2019. |
| 3.3 | Certificate of Designation of Series A Junior Participating Preferred Stock of Registrant | Exhibit 3.1 to the Current Report on Form 8-K filed with the SEC on August 31, 2023. |
| 4.1 | Rights Agreement, dated as of August 30, 2023, between the Registrant and Computershare Trust Company, N.A., as Rights Agent | Exhibit 4.1 to the Current Report on Form 8-K filed with the SEC on August 31, 2023. |
| 10.1 | Cooperation Agreement, by and among the Company, the entities and person listed on Exhibit A thereto, and the entities and person listed on Exhibit B thereto, dated February 14, 2023 | Exhibit 10.1 to the Current Report on Form 8-K filed with the SEC on February 15, 2024. |
| 10.2 | Loan Agreement, dated as of April 12, 2024, between LifeVantage Corporation and Bank of America, N.A. | Exhibit 10.1 to the Current Report on Form 8-K filed with the SEC on April 16, 2024. |
| 10.3 | Continuing and Unconditional Guaranty, dated as of April 12, 2024, among LifeVantage Corporation, as Borrower, Lifeline Nutraceuticals Corporation, as Guarantor, and Bank of America, N.A. | Exhibit 10.2 to the Current Report on Form 8-K filed with the SEC on April 16, 2024. |
| 10.4 | Security and Pledge Agreement, dated as of April 12, 2024, among LifeVantage Corporation, as Borrower, Lifeline Nutraceuticals Corporation, as Guarantor, and Bank of America, N.A. | Exhibit 10.3 to the Current Report on Form 8-K filed with the SEC on April 16, 2024. |
| 10.5 | Evolve Compensation Plan (Canada) | Filed herewith. |
| 10.6 | Evolve Compensation Plan (Mexico) | Filed herewith. |
| 10.7 | Evolve Compensation Plan (UK) | Filed herewith. |
| 10.8 | Evolve Compensation Plan (EU) | Filed herewith. |
| 31.1 | Certification of principal executive officer pursuant to Rule 13a-14(a)/15d-14(a) | Filed herewith. |
| 31.2 | Certification of principal financial officer pursuant to Rule 13a-14(a)/15d-14(a) | Filed herewith. |
| 32.1* | Certification of principal executive officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | Furnished herewith. |
| 32.2* | Certification of principal financial officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | Furnished herewith. |
| 101 | The following financial information from the Company’s quarterly report on Form 10-Q for the quarter ended March 31, 2024 formatted in Inline XBRL (extensible Business Reporting Language): (i) Unaudited Condensed Consolidated Balance Sheets at March 31, 2024 and June 30, 2023; (ii) Unaudited Condensed Consolidated Statements of Operations and Other Comprehensive Income for the three and nine months ended March 31, 2024 and 2023; (iii) Unaudited Condensed Consolidated Statement of Stockholders’ Equity for the three and nine months ended March 31, 2024 and 2023; (iv) Unaudited Condensed Consolidated Statements of Cash Flows for the nine months ended March 31, 2024 and 2023; and (v) Notes to Unaudited Condensed Consolidated Financial Statements, tagged as blocks of text. | Filed herewith. |
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101 | Filed herewith |
| * | This certification is being furnished solely to accompany this report pursuant to 18 U.S.C. 1350, and is not being filed for purposes of Section 18 of the Exchange Act and is not to be incorporated by reference into any filing of the registrant, whether made before or after the date hereof, regardless of any general incorporation language in such filing |
|---|
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.